BioCrossroads Names Summit SpeakersPosted: Updated:
Cook Group Inc. Chairman Steve Ferguson and Indiana University Health Chief Executive Officer Dan Evans are among the speakers for this year's Indiana Life Sciences Summit. Former U.S. Food and Drug Administration Commissioner Mark McClellan will deliver a keynote address at the October event.
July 17, 2013
Indianapolis, Ind. -- BioCrossroads and AlpInvest Partners today announced their speaker line up for tenth annual Indiana Life Sciences Summit on Tuesday, October 22, 2013 including Former Commissioner of the U.S. Food and Drug Administration Mark McClellan, M.D., Ph.D., who will deliver the morning keynote speech on the politics of innovation in healthcare. He joins leaders from Biomet, Cook Medical, Dow AgroSciences, Eli Lilly and Company, Roche Diagnostics, and WellPoint, among others, who are also speaking at the conference.
Panel topics and speakers include:
Indiana’s Answers to the Politics of Innovation in Healthcare
Steve Ferguson, Chairman, Cook Group
Sam Nussbaum, Executive Vice President, Clinical Health Policy/Chief Medical Officer, WellPoint
Jon Serbousek, President, Biomet Biologics
Alan Wright, Chief Medical Officer, Roche Diagnostics
The Indiana Biosciences Research Institute: A Collaboration to Innovate Smarter, Faster and Better
Moderator: Gerry Dick, President and Managing Editor, Grow INdiana Ventures / Host and Creator of Inside INdiana Business with Gerry Dick
Darren Carroll, Vice President of Corporate Development, Eli Lilly and Company
Dan Evans, President and CEO, Indiana University Health
Marietta Harrison, Associate Vice President for Research, Purdue University
David Johnson, President and CEO, BioCrossroads and Central Indiana Corporate Partnership
Walt Plosila, Senior Advisor, Battelle
Ryan Streeter, Senior Economic Policy Advisor/Deputy Policy Director, Indiana Governor Mike Pence
Adam Thies, Director, Department of Metropolitan Development, City of Indianapolis
D. Ry Wagner, Global New Ventures and Technology Leader, Dow AgroSciences
Weathering the Capital Crunch: Life Sciences Funding Opportunities and Challenges:
Aaron Davidson, Managing Director, H.I.G. BioVentures
John Diekman, Founder and Managing Partner, 5AM Ventures
James Garvey, Chairman and Managing Partner, SV Life Sciences
The Summit will be at the JW Marriott, downtown Indianapolis, and the annual life sciences reception will be hosted by Eli Lilly and Company and Cook Medical on the preceding evening, Monday, Oct. 21. Winners of the New Venture Competition will also be announced that evening. Sponsors of the conference include Faegre Baker Daniels, Indiana University, and Miles Printing.
BioCrossroads (www.biocrossroads.com) advances Indiana’s signature strengths in the life sciences by connecting with corporate, academic and philanthropic partners; facilitating investments in promising start ups and building new enterprises; and educating through conferences, reports and market development knowledge. The initiative supports the region's existing research and corporate strengths while encouraging new business development and has formed several new nonprofit organizations, including Indiana Health Information Exchange, Fairbanks Institute for Healthy Communities, BioCrossroadsLINX, OrthoWorx, and Datalys Center.